Agentic AI
Agents that do the reading.
Multi-step agents that search registers, patents and papers, cross-check what they find and hand a reviewer the evidence—with clear boundaries and visible human control.
Applied AI for pharma, biotech and life sciences
TechMils builds AI agents, models and data systems for biomedical teams. Grounded in evidence, linked to its sources and reviewed by people where it matters.
Fig. 01From question to checked answer
Which candidates deserve a closer look?
Two candidates are worth counsel's time. 0102 One waits on a timing question. 01 Every claim carries its source.
Public sources Patriage already reads
What we build
From one high-value workflow to a specialist AI product, we build around your data, your decisions and the way regulated work actually gets done.
Agentic AI
Multi-step agents that search registers, patents and papers, cross-check what they find and hand a reviewer the evidence—with clear boundaries and visible human control.
Applied AI & machine learning
Models, retrieval and data pipelines shaped around molecules, sequences, clinical text and regulatory records—the data general-purpose tools handle badly.
AI strategy & delivery
Use-case discovery, focused prototypes and production-minded delivery, for teams that want results without building a large in-house AI group.
Where we help
Biomedical decisions rest on scattered registers, papers and datasets. We build the systems that read them, connect them and show their working.
Patent, exclusivity and market evidence assembled per molecule and per market, so a long list becomes a shortlist.
See PatriagePapers, targets and compound data pulled into one searchable view, with every answer traced back to its source.
Discuss a projectPublic registers tracked, compared and summarised across markets, with gaps and conflicts flagged for a specialist.
Discuss a projectReliable data pipelines and machine-learning models for molecular, sequence and clinical datasets.
Discuss a projectOur pre-FTO (freedom-to-operate) intelligence service screens a molecule's global patent estate and public drug registers, then delivers an analyst-reviewed dossier: when markets open, who already sells there and what needs closer review.
Pre-FTO decision brief
Molecule A
Market access & priorities for review
Focus counsel review on the UK. Resolve the German timing constraint and US evidence gap.
How we work
We start with the decision, design around the evidence and keep human judgement where it matters.
More about TechMilsDefine the outcome, constraints and hand-offs before choosing the technology.
Keep sources, checks and uncertainty inspectable when decisions carry weight.
Design simple interfaces and outputs that fit the way your team actually works.
Who you work with
A machine-learning and bioinformatics researcher with more than a decade of experience turning noisy scientific and regulatory data into usable systems. He built Patriage end to end.
Start a conversation
Tell us what is slow, repetitive or hard to scale, from literature and registers to data pipelines. We'll help you find a practical next step.